Sec Form 13D Filing - Spiegel Jeffrey O. filing for SONO TEK CORP (SOTK) - 2022-03-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

(Amendment No. 1)

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

§ 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Sono-Tek Corporation

(Name of Issuer)

Common Stock $0.01 par value per share

(Title of Class of Securities)

835483108

(CUSIP Number)

Jeffrey O. Spiegel

417 Fifth Avenue, 11^th Floor

New York, NY 10016

(212) 478-4742

with copies to:

Marc A. Leaf

Faegre Drinker Biddle & Reath LLP

1177 Avenue of the Americas, 41^st Floor

New York, New York 10036

(212) 248-3140

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 8, 2022

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or, 240.13d-1(g), check the following box  ☐.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

Sono-Tek Corp.

SCHEDULE 13D

Sono-Tek Corp.

SCHEDULE 13D

Sono-Tek Corp.

SCHEDULE 13D

Sono-Tek Corp.

Item 1. Security and Issuer.

The class of equity security to which this statement on Schedule 13D relates is the common stock, par value $0.01 per share (the “Common Stock”), of Sono-Tek Corporation, a New York corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 2012 Rt. 9W Milton, NY 12547. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

Item 2. Identity and Background.

(a) This Statement is being filed jointly on behalf of the following persons (the “Reporting Persons”):

(b) The business address of each of the Reporting Persons is:

417 Fifth Avenue, Floor 11

New York, New York 10016

(c) The principal occupation of Mr. Spiegel is President of Randa Apparel & Accessories. The address of the organization in which such employment is conducted is:

417 Fifth Avenue, Floor 11

New York, New York 10016

(d) Not Applicable.

(e) Not Applicable.

(f) United States of America.

Item 3. Source and Amount of Funds or Other Consideration.

Not applicable.

SCHEDULE 13D

Sono-Tek Corp.

Item 4. Purpose of Transaction.

The purpose of the transactions reported herein is passive investment. The Reporting Persons do not have any plans to influence Issuer’s management or to enter into any actions or transactions that would trigger any other disclosure required by this Item 4.

Item 5. Interest in Securities of the Issuer.

(a) and (b). The following table sets forth the beneficial ownership, voting power, and dispositive power of each of the Reporting Persons with respect to the shares of Common Stock:

(c) On March 8, 2022, Jeffrey Spiegel transferred 78,217 shares of Common Stock, as a charitable contribution, to a donor advised fund administered by the Vanguard Charitable Endowment Program, a major independent donor advised fund sponsor (“Vanguard Charitable”). Vanguard Charitable is tax-exempt under Section 501(c)(3) of the Internal Revenue Code of 1986, as amended (the “Code”), and is classified as a public charity under Section 509(a)(1) of the Code. Mr. Spiegel does not retain any voting or dispositive power with respect to the shares so donated, which constitutes 100% of the shares of Common Stock previously held by Mr. Spiegel in his individual capacity.

(d) Beneficiaries of the Hantman Trust may have the right to receive dividends from, or proceeds from the sale of, shares of Common Stock beneficially owned by the Hantman Trust, and beneficiaries of the Heidi Spiegel Trust may have the right to receive dividends from, or proceeds from the sale of, shares of Common Stock beneficially owned by the Heidi Spiegel Trust, but no such interest relates to more than 5% of the class of Common Stock.

(e) As a result of the charitable donation described in paragraph (c) of this Item 5, on March 8, 2022, Mr. Spiegel ceased to be the beneficial owner of more than five percent of the Common Stock.

SCHEDULE 13D

Sono-Tek Corp.

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

There are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 or between such persons and any other person with respect to any securities of the Issuer, except that the agreements under which the Hantman Trust and the Heidi Spiegel Trust were established grant to Mr. Spiegel, as trustee, the power to vote and dispose of any securities held by such trusts, including the shares of Common Stock. Mr. Spiegel disclaims beneficial ownership of the shares held by the trusts.

There are no contracts, arrangements, understandings, or relationships between any of the Reporting Persons, or any of their respective affiliates, and the Issuer or any of its affiliates, or relating to the shares of Common Stock. None of the Reporting Persons hold any options or other rights to acquire additional securities of the Issuer.

Item 7. Material to Be Filed as Exhibits.

99.1 Joint Filing Agreement

Filed as an Exhibit to the Schedule 13-D filed by the Reporting Persons on January 18, 2022

SCHEDULE 13D

Sono-Tek Corp.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).